Duopharma Biotech Bhd (XKLS:7148) ROCE % : 4.28% (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Duopharma Biotech Bhd ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Duopharma Biotech Bhd's annualized ROCE % for the quarter that ended in Dec. 2023 was 4.28%.

Duopharma Biotech Bhd ROCE % Historical Data

The historical data trend for Duopharma Biotech Bhd's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duopharma Biotech Bhd ROCE % Chart

Duopharma Biotech Bhd Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

12.17

10.41

9.71

9.94

7.58

Duopharma Biotech Bhd Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															6.95	12.83	8.79	6.80	4.28

Duopharma Biotech Bhd ROCE % Calculation

Duopharma Biotech Bhd's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	80.947	/	( ( (1221.919 - 264.591)	+	(1345.135 - 166.728) )	/ 2 )
	=	80.947	/	( (957.328	+	1178.407)	/ 2 )
	=	80.947	/	1067.8675
	=	7.58 %

Duopharma Biotech Bhd's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	47.712	/	( ( (1383.502 - 333.065)	+	(1345.135 - 166.728) )	/ 2 )
	=	47.712	/	( ( 1050.437	+	1178.407 )	/ 2 )
	=	47.712	/	1114.422
	=	4.28 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Duopharma Biotech Bhd (XKLS:7148) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Duopharma Biotech Bhd ROCE % Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Duopharma Biotech Bhd (XKLS:7148) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, MYS, 41200

Website

https://www.duopharmabiotech.com

Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer and exporter of pharmaceutical products and medicines.

Duopharma Biotech Bhd (XKLS:7148) Headlines

No Headlines